End-stage cardiac amyloidosis is an often-fatal disease that affects the ability of the heart to function properly. In recent years, heart transplantation has emerged as a viable option for patients…Read More
HAC/TAC is proud to present the first-ever Canadian-specific ATTR Patient Summit
An event where we will be bringing together patients, families, physicians, healthcare professionals and industry in a weekend of knowledge exchange, shared experiences, and networking.
This ATTR Patient Summit will take place at the Hyatt Regency Hotel in downtown Toronto.
Amyloidosis is a group of complex, incurable diseases which are frequently misdiagnosed and under-recognised. To improve the diagnosis and management of patients with all types of amyloidosis, four multidisciplinary medical…Read More